MAFLD and inflammatory bowel disease: a prospective cohort study
MAFLD and inflammatory bowel disease: a prospective cohort study
Commented Articles
PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.
Read MoreMAFLD and inflammatory bowel disease: a prospective cohort study
Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model
Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model
NAFLD: Review of Management for Primary Care Providers
The authors considered NAFLD evaluation, diagnosis, and management in the primary care setting and endocrinology clinics.
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD
The authors investigated the superiority of MAFLD versus NAFLD in predicting the risk of atherosclerotic cardiovascular disease.
NAFLD and adverse pregnancy outcomes
The authors explore the relationship between maternal NAFLD and adverse pregnancy outcomes in different body mass index (BMI) groups.
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?
A discussion about the clinical evidence on all-cause and specific mortality of MAFLD.
COVID-19, mortality and NAFLD
The authors estimated chronic liver disease-related mortality trends among individuals with diabetes before and during the COVID-19 pandemic.
HTN, NAFLD and mortality
The authors aimed to examine the impact of HTN on survival outcomes in a longitudinal cohort of NAFLD patients.
Fibrosis-4 index reflects right ventricular function and prognosis in HFpEF
The authors investigated the prognostic implication of the FIB-4 index regarding right ventricular dysfunction in patients with HFpEF.
NAFL: FIB-4, a strong predictor of both all-cause mortality and liver-related adverse outcomes
The authors analysed data on 30 million patients categorised into three diagnostic groups: NAFLD, NASH, and at risk of NASH.
From NAFLD to MAFLD in terms of nurse perspective
An international consensus panel has produced an influential report renaming the disease from NAFLD to MAFLD and suggesting how the disease should be diagnosed.
MAFLD: a milestone in the history of fatty liver disease
Our growing understanding of the natural history and pathogenesis of MAFLD and the predominant role of metabolic dysfunction in this disease have evoked efforts to redefine fatty liver disease.